耀才团队: 250天线是阻力将是关键
耀才证券研究部团队称,隔晚(25日)美股三大指数个别发展,科技股造好带动纳指及标普500指数续创新高,但航空股及能源股下跌,加上苹果股价回软,拖累道指回落。中美就检讨首阶段贸易协议举行高层对话利好市场气氛,港股ADR个别发展,腾讯ADR升逾1%报551元水平,「黑期」今早变动不大,料恒指於周五(28日)期指结算前很大可能维持上落待变格局。港股处於业绩发布高峰期,今日(26日)多达154家公司公布业绩,较值得关注的是石药(01093.HK)、小米(01810.HK)、信达生物(01801.HK)、中手游(00302.HK)、众安在线(06060.HK)及碧桂园服务(06098.HK)之表现。
从技术上看,恒指近两个交易日仍迫近於25,500点水平左近拉锯,如前文所述,指数目前仍是上落待变之格局,而本周五为即月期指结算,一日恒指仍徘徊於100天及250天线之间,即24,500点至25,800点内,後市仍缺乏明确方向。
(笔者为证监会持牌人)~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.